Daniel Rastein, MD, MPH '20 C-Suite Advisor Since 2020
CEO | cassderma rx
Daniel N. Rastein is the CEO of “cassderma rx” Pharmaceutical Corporation and also the Founder of Compliance and Regulatory of America/C.A.R.A. Consulting Corporation. He has an extensive and distinguished background in research programmatic design and implementation to comply with local, state, federal and international health and safety regulations. He has previously served as Chief Compliance Officer at RadCore Labs, LLC, Compliagent, Inc. and Beacon Behavioral Solutions / Evolve Treatment Centers, including having served for more than a decade as a FDA GLP Research Compliance Officer for Cedars-Sinai Medical Center.
Daniel has also helped in the licensing, accreditation and regulatory programs for Stanford Medical Center, Stanford Lucile Packard Children’s Hospital, Children’s Hospital Los Angeles and the Children’s Oncology Group. Originally trained as a medical doctor, he decided to continue his studies and earned a Masters in Public Health at UCLA. Daniel has achieved numerous certifications and designations in the compliance field, including Healthcare Compliance Association (HCCA), Society of Quality Assurance (SQA), American Biological Safety Association (ABSA), British Association of Research Quality Assurance (BARQA).
He is an industry expert in the field of governmental regulations, from CMS to OIG to FDA to USDA. Daniel has been integrally involved in designing regulatory standards in the development of numerous drugs and biomedical devices for cutting edge manufacturing, research, medical, aerospace and agriculture companies. He is a faculty member, adviser and regular lecturer at the Institute for Medical Leadership, UCLA David Geffen School of Medicine, UCLA Fielding School of Public Health, USC International School of Regulatory Science.